In this study, we employed a combination of bioinformatics analyses and experimental methods to investigate WISP1 expression in ESCC, its association with clinical prognosis, its correlation with the TME, drug resistance, and response to immunotherapy, as well as the potential molecular mechanisms involved. The gene discussed is CCN4; the disease is esophageal squamous cell carcinoma.